CMPS Form 4: 52,000 director stock options granted at $6.33
Rhea-AI Filing Summary
COMPASS Pathways plc director Jeffrey M. Jonas reported an option grant to acquire 52,000 Ordinary Shares at an exercise price of $6.33 on October 29, 2025. The option vests in 36 equal monthly installments over three years, with the first tranche vesting on November 29, 2025, and expires on October 28, 2035. The options are held directly. Each American Depositary Share currently represents one Ordinary Share.
Positive
- None.
Negative
- None.
Insights
Routine director option grant; neutral for valuation.
COMPASS Pathways (CMPS) disclosed a standard equity award: options for 52,000 Ordinary Shares at an exercise price of $6.33 granted on October 29, 2025. This is typical director compensation and does not itself change operations or cash flow.
The award vests monthly over three years starting November 29, 2025 and expires on October 28, 2035, aligning incentives over time. ADS are 1:1 with Ordinary Shares as stated. No immediate dilution occurs unless options are exercised.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Share Option (Right to Buy) | 52,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. This option shall vest in 36 equal monthly installments over three years, with the first tranche vesting and becoming exercisable on November 29, 2025.
- F2. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
FAQ
What did COMPASS Pathways (CMPS) report in this Form 4?
What is the exercise price and size of the CMPS option grant?
How do the CMPS options vest?
When do the CMPS options expire?
Is the ownership of these options direct or indirect?
AI-generated analysis. How Rhea-AI works. Not financial advice.